Smartphone based therapy management is the future of diabetes treatment. Combine the mylife YpsoPump insulin pump, the mylife CamAPS FX mobile application and the Dexcom G6 Continuous Glucose Monitoring (CGM) System for an automated insulin delivery system managed directly from your smartphone. The integration of automated insulin delivery into the mylife YpsoPump system portfolio allows you time away from your diabetes and more freedom to do what you love doing.

*The innovation described is available in selected countries and expanding to further countries soon. Expansion is contingent upon Health Canada licensing.

Stay in the Loop

Stay informed about our mylife Loop? Fill out the form below and we promise to keep you in the Loop.

Your contact details

Note:
We only use the data you provide us on this form for the above-mentioned purpose. We do not save the data on this web server. For more information on the collection and processing of your data, please refer to our Privacy Policy.

What is the sum of 3 and 7?

* Mandatory fields

Disclaimer:

The product images are for illustrative purposes only.

CamAPS FX is a product of CamDiab Limited, Cambridge, UK.

Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. in the United States and/or other countries.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ypsomed is under license.

Other trademarks and trade names are those of their respective owners.

For safety information on mentioned products, see mylife-diabetescare.ca/safety